The Progress of Cerebral Preconditioning

Abstract

Abstract:

Stroke is the third most common cause of death after heart attack and cancer and has profound negative social and economic effects. Treatments for stroke are more concentrated in the acute period of stroke, and there is no effective method in the recovery period of stroke. Pharmacological treatments are either ineffective or confounded by adverse effects, and neuroprotection and brain repair in patients after acute brain damage are still major unfulfilled medical needs. Recently, endogenous mechanisms by which the brain protects itself against noxious stimuli and recovers from damage are being studied. Research on preconditioning, also known as induced tolerance, has resulted in various promising strategies for the treatment of patients with acute brain injury. On the one hand, preconditioning can identify endogenous protective or regenerative mechanisms that can be therapeutically induced. On the other hand, preconditioning could be used as a therapeutic technique by inducing tolerance in individuals in whom ischemic events are anticipated, such as high-risk surgical cohorts or patients with subarachnoid hemorrhage or transient ischemic attack.

Key words: Preconditioning; Post-conditioning; Cerebral protection

摘要：

卒中是第3位常见的致死原因，给社会和经济带来沉重的负担。针对卒中的治疗多集中在急性期，而卒中恢复期的治疗尚无有效方法。有关药物治疗或无效或存在不良影响，相应的神经保护和大脑修复仍然是主要的尚未实现的医疗需求。近年来，大脑保护自身免受伤害性刺激以及修复内源性修复损伤越来越受关注。其中，对预适应的研究（也被称为诱导耐受性）已产生多种有希望治疗急性颅脑损伤的方法。一方面，预适应可以识别那些被诱导出的内源性保护或再生机制；另一方面，对于那些预期会发生缺血性事件的人群（如接受过脑部手术、短暂性脑缺血发作或蛛网膜下腔出血的患者），预适应可以作为一种治疗手段来诱导出耐受性。

关键词: 预适应; 后处理; 脑保护

ZHAO Yi-Long*, GUO An-Chen, WANG Yong-Jun, WANG Qun.. The Progress of Cerebral Preconditioning[J]. Chinese Journal of Stroke, 2015, 10(02): 135-140.

赵一龙1-4，郭安臣2-4，王拥军1-4，王群1-4. 脑预适应保护研究进展[J]. 中国卒中杂志, 2015, 10(02): 135-140.

References

1 Stetler RA, Leak RK, Gan Y, et al. Preconditioning

prov ide s neu roprot e c t ion i n model s of CNS

disease:paradigms and clinical significance[J]. Prog

Neurobiol, 2014, 114:58-83.

2 Schurr A, Reid KH, Tseng MT, et al. Adaptation of

adult brain tissue to anoxia and hypoxia in vitro[J].

Brain Res, 1986, 374:244-248.

3 Kitagawa K, Matsumoto M, Kuwabara K, et al.

'Ischemic tolerance' phenomenon found in the brain[J].

Brain Res, 1990, 528:21-24.4

4 Dirnagl U, Becker K, Meisel A. Preconditioning

and tolerance against cerebral ischaemia:from

experimental strategies to clinical use[J]. Lancet

Neurol, 2009, 8:398-412.

5 Zh a o H. Th e p r ot e c t ive e f f e c t of i s ch emi c

postconditioning against ischemic injury:from the

heart to the brain[J]. J Neuroimmune Pharmacol,

2007, 2:313-318.

6 Gidday JM. Cerebral preconditioning and ischaemic

tolerance[J]. Nat Rev Neurosci, 2006, 7:437-448.

7 Pignataro G, Scorziello A, Di Renzo G, et al.

Post-ischemic brain damage:effect of ischemic

p r e c o n d i t io n i n g a n d p o s t c o n d i t io n i n g a n d

identification of potential candidates for stroke

therapy[J]. FEBS J, 2009, 276:46-57.

8 Gill R. Remote ischemic precondit ioning for

myocardial protection:update on mechanisms and

clinical relevance[EB/OL]. (2015-01-01)[2015-01-10].

http://link.springer.com/article/10.1007%2Fs11010-

014-2312-z.

9 Dirnagl U, Simon RP, Hallenbeck JM. Ischemic

tolerance and endogenous neuroprotection[J]. Trends

Neurosci, 2003, 26:248-254.

10 Barone FC, White RF, Spera PA, et al. Ischemic

preconditioning and brain tolerance:temporal

histological and functional outcomes, protein

synthesis requirement, and interleukin-1 receptor

antagonist and early gene expression[J]. Stroke, 1998,

29:1937-1931.

11 Ob r e n o v i t c h T P. Mo l e c u l a r p h y s i o l o g y of

pr e cond it ion i ng-i nduc e d br a i n t ole r a nc e t o

ischemia[J]. Physiol Rev, 2008, 88:211-247.

12 Wi l l i ams -Ka r ne sk y RL, St e n z e l -Po or e MP.

Adenosine and stroke:maximizing the therapeutic

potential of adenosine as a prophylactic and acute

neuroprotectant[J]. Curr Neuropharmacol, 2009,

7:217-227.

13 Kunz A, Pa rk L, Abe T, et al. Neurovascula r

protection by ischemic tolerance:role of nitric oxide

and reactive oxygen species[J]. J Neurosci, 2007,

27:7083-7093.

14 Yamaguchi T, Kamada K, Dayton C, et al. Role

of eNOS-derived NO in the postischemic antiinflammatory

effects of antecedent ethanol ingestion

in murine small intestine[J]. Am J Physiol Heart Circ

Physiol, 2007, 292:H1435-1442.15.

15 Yusof M, Kamada K, Kalogeris T, et al. Hydrogen

sulf ide t r iggers late-phase preconditioning in

postischemic small intestine by an NO- and p38

MAPK-dependent mechanism[J]. Am J Physiol Heart

Circ Physiol, 2009, 296:H868-876.

16 Gáspár T, Katakam P, Snipes JA, et al. Delayed

neuronal preconditioning by NS1619 is independent

of calcium activated potassium channels[J]. J

Neurochem, 2008, 105:1115-1128.

17 Collins MA, Neafsey EJ, Mukamal KJ, et al.

Alcohol in moderat ion, cardioprotect ion, and

neuroprotection:epidemiological considerations and

mechanistic studies[J]. Alcohol Clin Exp Res, 2009,

33:206-219.

18 Raval AP, Lin HW, Dave KR, et al. Resveratrol and

ischemic preconditioning in the brain[J]. Curr Med

Chem, 2008, 15:1545-1551.

19 Ta n L, Yu JT, Gu a n HS. Re sve r a t rol exe r t s

pharmacological preconditioning by activating PGC-1

alpha[J]. Med Hypotheses, 2008, 71:664-667.

20 Della-Mor te D, Dave KR, Defa z io RA, et al.

Resveratrol pretreatment protects rat brain from

cerebral ischemic damage via a sirtuin 1-uncoupling

protein 2 pathway[J]. Neuroscience, 2009, 159:993-

1002.

21 Saleh MC, Connell BJ, Saleh TM. Resveratrol

preconditioning induces cellular stress proteins and

is mediated via NMDA and estrogen receptors[J].

Neuroscience, 2010, 166:445-454.

22 Xu X, Kim JA, Zuo Z. Isoflurane preconditioning

reduces mouse microglial activation and injury

induced by lipopolysacchar ide and interferongamma[

J]. Neuroscience, 2008, 154:1002-1008.

23 Li L, Zuo Z. Isof lurane preconditioning improves

short-term and long-term neurological outcome after

focal brain ischemia in adult rats[J]. Neuroscience,

2009, 164:497-506.

24 Gulati P, Singh N. Pharmacological evidence for

connection of nit r ic oxide-mediated pathways

i n n e u r o p r ot e c t ive me ch a n i sm of i s ch emi c

postconditioning in mice[J]. J Pharm Bioallied Sci,

2014, 6:233-240.

25 Staat P, Rioufol G, Piot C, et al. Postconditioning the

human heart[J]. Circulation, 2005, 112:2143-2148.

26 Zhao H, Sapolsky RM, Steinberg GK. Interrupting

r e p e r f u s i o n a s a s t r o k e t h e r a p y : i s c h emi c

postconditioning reduces infarct size after focal

ischemia in rats[J]. J Cereb Blood Flow Metab, 2006,

26:1114-1121.

27 Pignataro G, Meller R, Inoue K, et al. In vivo and

in vitro characterization of a novel neuroprotective

strategy for stroke:ischemic postconditioning[J]. J

Cereb Blood Flow Metab, 2008, 28:232-241.

28 Sc a r t ab el l i T, Ge r a c e E, La nduc c i E, e t a l .

Neuroprotection by group I mGlu receptors in a

rat hippocampal slice model of cerebral ischemia

i s a s s o c i a t e d wi t h t h e PI 3K-Ak t s ig n a l i n g

pathway:a novel postconditioning strategy?[J].

Neuropharmacology, 2008, 55:509-516.

29 Wang C, Neff DA, Krolikowski JG, et al. The

i nf luenc e of B- c el l lymphoma 2 prot ei n, a n

antiapoptotic regulator of mitochondrial permeability

transition, on isof lurane-induced and ischemic

postconditioning in rabbits[J]. Anesth Analg, 2006,

102:1355-1360.

30 Oba l D, Det twi le r S, Favoc cia C, et a l. The

inf luence of mitochondrial KATP-channels in

the c a rdioprot e c t ion of pr e condit ion i ng a nd

postconditioning by sevoflurane in the rat in vivo[J].

Anesth Analg, 2005, 101:1252-1260.

31 Chia r i PC, Bieneng r a ebe r MW, Pagel PS, et

a l . I s of lu r a n e p r o t e c t s a g a i n s t myo c a r d i a l

infarction during early reperfusion by activation

o f p h o s p h a t i d y l i n o s i t o l -3 - k i n a s e s i g n a l

t ransduct ion:evidence for anesthet ic-induced

postconditioning in rabbits[J]. Anesthesiology, 2005,

102:102-109.

32 Fan YY, Hu WW, Dai HB, et al. Activation of the

central histaminergic system is involved in hypoxiainduced

stroke tolerance in adult mice[J]. J Cereb

Blood Flow Metab, 2011, 31:305-314.

33 Soejima Y, Ost rowski RP, Manaenko A, et al.

Hyperbaric oxygen preconditioning attenuates

hyperglycemia enhanced hemorrhagic transformation

after transient MCAO in rats[J]. Med Gas Res, 2012, 2:9.

34 Yuan HB, Huang Y, Zheng S, et al. Hypothermic

preconditioning reduces Purkinje cell death possibly

by preventing the over-expression of inducible nitric

oxide synthase in rat cerebellar slices after an in vitro

simulated ischemia[J]. Neuroscience, 2006, 142:381-

389.35

35 Su Z, Han D, Sun B, et al. Heat stress preconditioning

improves cognitive outcome after diffuse axonal

injury in rats[J]. J Neurotrauma, 2009, 26:1695-1706.

36 Zigmond MJ, Came ron JL, Hof fe r BJ, e t a l.

Neurorestoration by physical exercise:moving

forward[J]. Parkinsonism Relat Disord, 2012, 18:S147-

150.

37 Cerqueira FM, Cunha FM, Laurindo FR, et al. Calorie

restriction increases cerebral mitochondrial respiratory

capacity in a NO*-mediated mechanism:impact on

neuronal survival[J]. Free Radic Biol Med, 2012,

52:1236-1241.

38 Pepping JK, Freeman LR, Gupta S, et al. NOX2

deficiency attenuates markers of adiposopathy and

brain injury induced by high-fat diet[J]. Am J Physiol

Endocrinol Metab, 2013, 304:E392-E404.

[1]	LIU Xudong, LIU Meng, SU Ying, ZHOU Yanxia, REN Lijie. Current Research in the Mechanism and Clinical Application about Remote Ischemic Preconditioning in Cerebral Infarction [J]. Chinese Journal of Stroke, 2024, 19(1): 105-111.
[2]	ZHAO Yi-Long, GUO An-Chen, SU Fang, et al.. Study on Protective Effects of Moderate Ethanol Preconditioning Against Brain Injury-induced by Focal Cerebral Ischemia / Reperfusion in Rats [J]. Chinese Journal of Stroke, 2016, 11(05): 378-385.
[3]	SU Fang*, ZHU Yu-Lan, GUO An-Chen, WANG Yong-Jun, WANG Qun.. Biomarkers for Cerebral Ischemic Preconditioning [J]. Chinese Journal of Stroke, 2015, 10(02): 147-152.
[4]	MA Xiao-Meng;CHEN Xiao-Hong.. Advancement in Integrin AlphaVbeta3 and Ischemic Cerebrovascular Disease Study [J]. , 2010, 5(12): 1015-1018.
[5]	ZHAO Ren-liang;DONG Rui-jian.. Expression of Hypoxia Inducible Factor-1α and Erythropoietin in the Rat Model of Brain Ischemic Tolerance [J]. , 2007, 2(02): 109-114.